Brief: Eagle Pharmaceuticals Provides Business Update And Reiterates 2023 Guidance
15/06/2023 11:57
June 15 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REITERATES
2023 GUIDANCE
* EAGLE PHARMACEUTICALS INC: AS WE APPROACH MIDYEAR 2023,
OUR
BUSINESS REMAINS STRONG
* EAGLE PHARMACEUTICALS INC: ARE PLEASED WITH POSITIVE
GROWTH
TRAJECTORY IN OUR KEY COMMERCIAL PRODUCTS
* EAGLE PHARMACEUTICALS INC - WE ANTICIPATE EXPANDING
PORTFOLIO
THROUGH PIPELINE SUCCESS AND POTENTIAL ACQUISITION
Source text for Eikon: ID:nGNX8THwbR
Further company coverage: EGRX.O
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq